ELN  Elan Corporation Plc

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

9.293B

Vuru Grade

17.88/100

Current Price

$18.12
0.00 (0.00%)

Company Metrics

  • P/E 4.07
  • P/S 88.25
  • P/B 4.45
  • EPS 0
  • Cash ROIC -17.28%
  • Cash Ratio -
  • Dividend 0 / 0%
  • Avg. Vol. 360,607.00
  • Shares 512.86M
  • Market Cap. 9.293B

Company Description

Elan Corporation, plc operates as a neuroscience-based biotechnology company primarily in Ireland and the United States. It operates in two segments, BioNeurology and Elan Drug Technologies (EDT). The BioNeurology segment engages in the research, development, and commercial activities primarily in the areas of Alzheimer's disease, Parkinson's disease, multiple sclerosis (MS), and Crohn's disease. ... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

There is no news available at this time.